Review

Ashwagandha: A Flagship Herb of Ayurveda from Past to Present Nano Era

Shefali Arora1★, Krishna Samanta1, Sukanya Chettri1, Devendra Rawat1, Versha Percha2, Deepak Kumar2★ Corresponding author

  1. 1Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, INDIA.
  2. 2Department of Pharmaceutical Chemistry, Dolphin (PG) Institute of Biomedical and Natural Sciences, Dehradun, Uttarakhand, INDIA.

CORRESPONDENCE

Shefali Arora

Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, INDIA.

shefali.arora@ddn.upes.ac.in

Received: 09-01-2023; Revised: 28-02-2023; Accepted: 05-05-2023.

Volume 13, Issue 3 · pp. 393–401 · PUBLISHED · DOI: 10.5530/ijpi.13.3.050

View on IJPI original site ↗

ABSTRACT

Plants are considered excellent resources for the generation of greener biomaterials. Plant extract are renewable in nature. Various metabolites present in plant extract are normally used in redox reaction for the formation of eco-friendly nano-particles. It is also considered as the main factory for the green synthesis of metal nano-particles. The plant-based nano-particles is very necessary for absolute harmony connection between plant science and nanotechnology. Ashwagandha is the non-toxic herb which used to treat a range of conditions and its life changing benefits runs over a long time. Its numerous medicinal values make this plant so popular. It is a stress buster which works for all “SUPERHERB”. This super herb rejuvenates our body and brain from the inside out. Present review depicts the variety of assistance of Ashwagandha plant with or without nanoparticles, from the past to the present time of corona.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Arora, S., Samanta, K., Chettri, S., Rawat, D., Percha, V., & Kumar, D. (). Ashwagandha: A Flagship Herb of Ayurveda from Past to Present Nano Era. International Journal of Pharmaceutical Investigation, 13(3), 393–401. https://doi.org/10.5530/ijpi.13.3.050